Variant report

Variant	esv3489906
Chromosome Location	chr14:104601599-104603797
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:289)
CpG islands
(count:366)
Chromatin interactive
region (count:12)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:289 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr14:104603605-104604731	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr14:104601446-104601766	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr14:104602998-104603136	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr14:104602373-104602569	H1-hESC	embryonic stem cell:	n/a	n/a
5	CREB1	chr14:104603737-104604764	H1-hESC	embryonic stem cell:	n/a	n/a
6	CTBP2	chr14:104603716-104604582	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTCF	chr14:104601494-104601707	ProgFib	skin:	n/a	n/a
8	CTCF	chr14:104601380-104601781	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr14:104601540-104601690	SAEC	small airway:	n/a	n/a
10	CTCF	chr14:104601480-104601630	Caco-2	colon:	n/a	n/a
11	CTCF	chr14:104603609-104604492	HCT-116	colon:	n/a	chr14:104603991-104604004 chr14:104603989-104604005 chr14:104603988-104604006 chr14:104603990-104604011
12	CTCF	chr14:104601480-104601630	MCF-7	breast:	n/a	n/a
13	CTCF	chr14:104601441-104601656	A549	lung:	n/a	n/a
14	CTCF	chr14:104601484-104601697	Fibrobl	skin:	n/a	n/a
15	CTCF	chr14:104601358-104601751	H1-hESC	embryonic stem cell:	n/a	n/a
16	CTCF	chr14:104603760-104604215	H1-hESC	embryonic stem cell:	n/a	chr14:104603991-104604004 chr14:104603989-104604005 chr14:104603988-104604006 chr14:104603990-104604011
17	CTCF	chr14:104603080-104603230	SAEC	small airway:	n/a	chr14:104603148-104603161
18	CTCF	chr14:104601416-104601729	T-47D	breast:	n/a	n/a
19	CTCF	chr14:104601480-104601630	HCM	heart:	n/a	n/a
20	CTCF	chr14:104601500-104601650	A549	lung:	n/a	n/a
21	CTCF	chr14:104601445-104601736	MCF-7	breast:	n/a	n/a
22	CTCF	chr14:104601484-104601688	HUVEC	blood vessel:	n/a	n/a
23	CTCF	chr14:104601532-104601648	GM19239	blood:	n/a	n/a
24	CTCF	chr14:104603776-104604178	A549	lung:	n/a	chr14:104603991-104604004 chr14:104603989-104604005 chr14:104603988-104604006 chr14:104603990-104604011
25	CTCF	chr14:104602460-104602610	HRPEpiC	eye:	n/a	chr14:104602502-104602515
26	CTCF	chr14:104601447-104601726	Gliobla	brain:	n/a	n/a
27	CTCF	chr14:104602578-104602590	Lung_OC	lung:	n/a	n/a
28	CTCF	chr14:104601426-104601780	A549	lung:	n/a	n/a
29	CTCF	chr14:104601559-104601652	Kidney_OC	kidney:	n/a	n/a
30	CTCF	chr14:104601540-104601690	GM12873	blood:	n/a	n/a
31	CTCF	chr14:104601520-104601670	GM12874	blood:	n/a	n/a
32	CTCF	chr14:104601480-104601630	HMEC	breast:	n/a	n/a
33	CTCF	chr14:104601500-104601650	HUVEC	blood vessel:	n/a	n/a
34	CTCF	chr14:104601520-104601658	IMR90	lung:	n/a	n/a
35	CTCF	chr14:104601520-104601670	Hela-S3	cervix:	n/a	n/a
36	CTCF	chr14:104602460-104602610	HBMEC	blood vessel:	n/a	chr14:104602502-104602515
37	CTCF	chr14:104601620-104601770	NHEK	skin:	n/a	n/a
38	CTCF	chr14:104602460-104602610	WERI-Rb-1	eye:	n/a	chr14:104602502-104602515
39	CTCF	chr14:104601523-104601633	K562	blood:	n/a	n/a
40	CTCF	chr14:104602280-104602430	BJ	skin:	n/a	n/a
41	CTCF	chr14:104601520-104601670	GM12872	blood:	n/a	n/a
42	CTCF	chr14:104603791-104604139	GM19240	blood:	n/a	chr14:104603991-104604004 chr14:104603989-104604005 chr14:104603988-104604006 chr14:104603990-104604011
43	CTCF	chr14:104602860-104603010	WERI-Rb-1	eye:	n/a	chr14:104602912-104602925
44	CTCF	chr14:104601500-104601650	HBMEC	blood vessel:	n/a	n/a
45	CTCF	chr14:104601480-104601630	BE2_C	brain:	n/a	n/a
46	CTCF	chr14:104601500-104601650	NHDF-neo	bronchial:	n/a	n/a
47	CTCF	chr14:104603752-104604268	MCF-7	breast:	n/a	chr14:104603991-104604004 chr14:104603989-104604005 chr14:104603988-104604006 chr14:104603990-104604011
48	CTCF	chr14:104601520-104601670	AG04449	skin:	n/a	n/a
49	CTCF	chr14:104601480-104601630	SAEC	small airway:	n/a	n/a
50	CTCF	chr14:104602858-104602909	Medullo	brain:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr14:104602875-104602925	SK-N-SH_RA	brain:	n/a
2	chr14:104603143-104603193	HEK293	kidney:	embryo
3	chr14:104602875-104602925	T-47D	breast:	n/a
4	chr14:104603559-104603609	PANC-1	pancreas:	n/a
5	chr14:104602875-104602925	HCF	heart:	n/a
6	chr14:104603143-104603193	ovcar-3	ovarian:	n/a
7	chr14:104603559-104603609	SAEC	small airway:	n/a
8	chr14:104603559-104603609	HRE	kidney:	n/a
9	chr14:104602875-104602925	HMEC	breast:	n/a
10	chr14:104603559-104603609	AG04449	skin:	fetal
11	chr14:104603559-104603609	LNCaP	prostate:	n/a
12	chr14:104603440-104603490	SK-N-SH	brain:	n/a
13	chr14:104603238-104603288	AG09309	skin:	n/a
14	chr14:104603143-104603193	ECC-1	luminal epithelium:	n/a
15	chr14:104603559-104603609	PFSK-1	brain:	n/a
16	chr14:104602875-104602925	NB4	blood:	n/a
17	chr14:104603440-104603490	U87	brain:	n/a
18	chr14:104603559-104603609	GM12878	blood:	n/a
19	chr14:104603238-104603288	LNCaP	prostate:	n/a
20	chr14:104603559-104603609	H1-hESC	embryonic stem cell:	embryo
21	chr14:104603238-104603288	PrEC	prostate:	n/a
22	chr14:104603238-104603288	HPAEpiC	pulmonary alveolar:	n/a
23	chr14:104602474-104602524	ovcar-3	ovarian:	n/a
24	chr14:104603143-104603193	SK-N-MC	brain:	n/a
25	chr14:104603143-104603193	HepG2	liver:	n/a
26	chr14:104602875-104602925	SAEC	small airway:	n/a
27	chr14:104603143-104603193	PFSK-1	brain:	n/a
28	chr14:104603559-104603609	NB4	blood:	n/a
29	chr14:104602875-104602925	HIPEpiC	eye:	n/a
30	chr14:104603143-104603193	HCPEpiC	choroid plexus:	n/a
31	chr14:104603440-104603490	PFSK-1	brain:	n/a
32	chr14:104603559-104603609	HCF	heart:	n/a
33	chr14:104603559-104603609	AoSMC	blood vessel:	n/a
34	chr14:104602875-104602925	HNPCEpiC	eye:	n/a
35	chr14:104603559-104603609	A549	lung:	n/a
36	chr14:104603559-104603609	HPAEpiC	pulmonary alveolar:	n/a
37	chr14:104603238-104603288	SK-N-SH_RA	brain:	n/a
38	chr14:104602875-104602925	HCPEpiC	choroid plexus:	n/a
39	chr14:104603238-104603288	T-47D	breast:	n/a
40	chr14:104603440-104603490	HUVEC	blood vessel:	n/a
41	chr14:104603238-104603288	HEEpiC	esophagus:	n/a
42	chr14:104603238-104603288	MCF-7	breast:	n/a
43	chr14:104603559-104603609	HCM	heart:	n/a
44	chr14:104603143-104603193	A549	lung:	n/a
45	chr14:104603143-104603193	HIPEpiC	eye:	n/a
46	chr14:104602875-104602925	PFSK-1	brain:	n/a
47	chr14:104603143-104603193	AG10803	skin:	n/a
48	chr14:104603238-104603288	HRPEpiC	eye:	n/a
49	chr14:104603143-104603193	MCF-7	breast:	n/a
50	chr14:104602875-104602925	HUVEC	blood vessel:	n/a

(count:12 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr14:104601150..104601941-chr14:105106059..105106643,2	MCF-7	breast:
2	chr14:104600334..104603089-chr14:104739484..104741726,2	MCF-7	breast:
3	chr14:104544173..104544867-chr14:104600427..104602112,4	MCF-7	breast:
4	chr14:104601273..104602911-chr14:105124192..105126069,2	MCF-7	breast:
5	chr14:104544255..104544937-chr14:104603467..104604144,3	MCF-7	breast:
6	chr14:104602797..104606014-chr14:105189341..105192191,3	MCF-7	breast:
7	chr14:104601133..104601983-chr14:105106088..105106710,2	MCF-7	breast:
8	chr14:104599830..104602632-chr14:105024556..105026842,2	MCF-7	breast:
9	chr14:104600527..104602291-chr14:104606729..104609262,2	K562	blood:
10	chr14:104603534..104604192-chr14:105028243..105029014,2	MCF-7	breast:
11	chr14:104603491..104604109-chr14:104836400..104837109,2	MCF-7	breast:
12	chr14:104601077..104602107-chr14:105029674..105030837,6	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TDRD9-AS1-1	chr14:104603487-104603579	ENSG00000258748.1

No data

Variant related genes	Relation type
KIF26A	TF binding region
KIF26A	CpG island
ENSG00000185100	chromatin interactions

Extended variants
information (count: 76 )
Associated
traits (count: 100 )

Variant overlapped rSNPs/rCNVs (count:76 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs374822381	chr14:104601602-104601603	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs576431094	chr14:104601614-104601615	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs561313771	chr14:104601616-104601617	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs370907213	chr14:104601617-104601618	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs543846252	chr14:104601619-104601620	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs546739102	chr14:104601633-104601634	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs566959257	chr14:104601680-104601681	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs373441062	chr14:104601719-104601720	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs538427779	chr14:104601725-104601726	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs552383116	chr14:104601740-104601741	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs145614501	chr14:104601753-104601754	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs535689789	chr14:104601788-104601789	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs28533786	chr14:104601826-104601827	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs183500972	chr14:104601842-104601843	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs537794143	chr14:104601853-104601854	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs188957210	chr14:104601855-104601856	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs574053042	chr14:104601874-104601875	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs76084795	chr14:104601887-104601888	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs553555548	chr14:104601898-104601899	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs368552284	chr14:104601980-104601981	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs572436791	chr14:104602006-104602007	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs193243425	chr14:104602029-104602030	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs528713864	chr14:104602032-104602033	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs535010225	chr14:104602057-104602058	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs565504865	chr14:104602061-104602062	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs576007752	chr14:104602064-104602065	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs544963911	chr14:104602087-104602088	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs561577441	chr14:104602131-104602132	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs116326502	chr14:104602148-104602149	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs12587001	chr14:104602177-104602178	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs560368497	chr14:104602257-104602258	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs370912716	chr14:104602336-104602337	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs145365793	chr14:104602354-104602355	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs577065526	chr14:104602359-104602360	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs568751407	chr14:104602396-104602397	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs118126433	chr14:104602410-104602411	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs367979881	chr14:104602459-104602460	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs548032167	chr14:104602485-104602486	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
39	rs182707971	chr14:104602499-104602500	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs370808267	chr14:104602501-104602502	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs533517185	chr14:104602587-104602588	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs553767897	chr14:104602620-104602621	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs113132038	chr14:104602720-104602721	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs576846152	chr14:104602793-104602794	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs149183118	chr14:104602801-104602802	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs375902982	chr14:104602896-104602897	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs575868303	chr14:104602907-104602908	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs187779999	chr14:104602945-104602946	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs561537765	chr14:104602970-104602971	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs575227378	chr14:104602983-104602984	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:100)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	17899364	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Chronic myeloid leukemia	20724749	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Colorectal cancer	16774939	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Neuroblastoma	18923191	CNVD
Barrett''s syndrome	19417022	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
cataract	16735990	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Developmental delay	21147756	CNVD
Cancer	20164920	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Biliary cancer	19435499	CNVD
Follicular lymphoma	20505157	CNVD
Acute lymphoblastic leukemia	20139093	CNVD
Hepatocellular carcinoma	16750200	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Glioblastoma multiforme	21922591	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	22174824	CNVD
Non-small cell lung cancer	18320023	CNVD
Melanoma	17363583	CNVD
Prostate cancer	18632612	CNVD
Congenital heart defect	22367666	CNVD
Developmental delay	22367666	CNVD
Genitourinary abnormalities	22367666	CNVD
Intellectual disability	22367666	CNVD
Microcephaly	22367666	CNVD
Muscularhypotonia	22367666	CNVD
Ocular coloboma	22367666	CNVD
Teratozoospermia	22367666	CNVD
Cervical cancer	21062161	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	21990379	CNVD
Breast cancer	16417655	CNVD
22q11 deletion syndrome	22511897	CNVD
Cancer	21129771	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Schizophrenia	21399695	CNVD
Intracranial ependymoma	16609018	CNVD
Lung adenocarcinoma	17086460	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
14q deletion syndrome	22511897	CNVD
Epilepsy	22083797	CNVD
Urothelial carcinoma	21177765	CNVD
Ovarian cancer	21720365	CNVD
Cancer	17440070	CNVD
Neurocytoma	17123091	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Central neurocytomas	17123091	CNVD
Acute lymphoblastic leukemia	17315016	CNVD
Lung cancer	17086460	CNVD
Mortal	21835882	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	17426248	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD

Chromatin state (count:335 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:104597800-104601800	Weak transcription	Pancreas	Pancrea
2	chr14:104600200-104601600	Bivalent Enhancer	Brain Germinal Matrix	brain
3	chr14:104600600-104601600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
4	chr14:104600600-104602000	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
5	chr14:104600600-104602600	Bivalent Enhancer	Fetal Lung	lung
6	chr14:104600800-104602000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
7	chr14:104600800-104604200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
8	chr14:104601000-104602000	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
9	chr14:104601000-104602000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
10	chr14:104601200-104601600	Active TSS	H9 Cell Line	embryonic stem cell
11	chr14:104601200-104601600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
12	chr14:104601200-104601800	Bivalent Enhancer	A549	lung
13	chr14:104601200-104602000	Bivalent Enhancer	Fetal Heart	heart
14	chr14:104601200-104602200	Bivalent Enhancer	Fetal Stomach	stomach
15	chr14:104601200-104602400	Bivalent Enhancer	Fetal Intestine Small	intestine
16	chr14:104601200-104603200	Bivalent Enhancer	Fetal Brain Male	brain
17	chr14:104601200-104604000	Bivalent Enhancer	Spleen	Spleen
18	chr14:104601200-104605600	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
19	chr14:104601400-104601600	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
20	chr14:104601400-104601600	Flanking Bivalent TSS/Enh	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr14:104601400-104601600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
22	chr14:104601400-104601600	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
23	chr14:104601400-104601600	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
24	chr14:104601400-104601600	Bivalent Enhancer	Fetal Brain Female	brain
25	chr14:104601400-104601800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
26	chr14:104601400-104601800	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr14:104601400-104601800	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
28	chr14:104601400-104602000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr14:104601400-104602400	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
30	chr14:104601400-104602400	Enhancers	Primary hematopoietic stem cells	blood
31	chr14:104601400-104604000	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr14:104601400-104606600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
33	chr14:104601600-104601800	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
34	chr14:104601600-104601800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
35	chr14:104601600-104601800	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
36	chr14:104601600-104601800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
37	chr14:104601600-104601800	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
38	chr14:104601600-104601800	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
39	chr14:104601600-104602000	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
40	chr14:104601600-104602000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
41	chr14:104601600-104602000	Bivalent Enhancer	Colonic Mucosa	Colon
42	chr14:104601600-104602000	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
43	chr14:104601600-104602200	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
44	chr14:104601600-104602200	Bivalent Enhancer	Brain Dorsolateral Prefrontal Cortex	brain
45	chr14:104601600-104602200	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
46	chr14:104601600-104602200	Bivalent Enhancer	Stomach Smooth Muscle	stomach
47	chr14:104601600-104602400	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
48	chr14:104601600-104602400	Bivalent Enhancer	Duodenum Mucosa	Duodenum
49	chr14:104601600-104602400	Bivalent Enhancer	Fetal Muscle Leg	muscle
50	chr14:104601600-104602400	Bivalent Enhancer	Ovary	ovary

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links